Dolo-650 bribery allegation: Why pharma cos need tight monitoring
Dolo-650 manufacturer struck gold during the pandemic; was raided by IT in July, accusing it of bribing doctors through ₹1,000 crore “freebies” to push drug sale during the pandemic
dolo
October 2022
July 2022
February 2022
Dolo-650 maker doled out freebies worth ₹1,000 cr to doctors: I-T Dept
The Income Tax Department carried out search and seizure operations on the Bengaluru-based pharmaceutical group on July 6.
Covid-19 effect: Dolo, Augmentin top selling medicines in Jan
Dolo saw a 210% growth while Augmentin 62% in January 2022 as against the same month last year.
